Nicole Mowad-Nassar
Fortuna: 148 073 $ al 31/05/2026
Fortuna: 148 073 $ al 31/05/2026
Ms. Nicole Mowad-Nassar is an Independent Non-Executive Director at ResMed, Inc. and a Vice President-Marketing at Takeda Pharmaceuticals U.S.A., Inc. She is on the Board of Directors at ResMed, Inc. Ms. Mowad-Nassar was previously employed as a Senior Vice President & President-Specialty by AbbVie, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RESMED INC. 0 % | 24/11/2025 | 777 ( 0 % ) | 148 073 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RESMED, INC. | Director/Miembro de la Junta | 15/08/2025 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Ventas & Marketing | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/09/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
ResMed, Inc.
ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.